Inovio Pharmaceuticals, Inc.
INO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $66 | $14 | $46 | $71 |
| Short-Term Investments | $28 | $131 | $207 | $330 |
| Receivables | $1 | $2 | $12 | $8 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $3 | $5 | $51 | $39 |
| Total Curr. Assets | $98 | $153 | $315 | $448 |
| Property Plant & Equip (Net) | $12 | $14 | $18 | $29 |
| Goodwill | $0 | $0 | $11 | $11 |
| Intangibles | $0 | $0 | $2 | $3 |
| Long-Term Investments | $2 | $3 | $2 | $4 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $2 | $1 | $1 | $1 |
| Total NC Assets | $15 | $18 | $33 | $47 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $113 | $171 | $349 | $496 |
| Liabilities | – | – | – | – |
| Payables | $6 | $5 | $21 | $28 |
| Short-Term Debt | $2 | $19 | $3 | $3 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $26 | $19 | $73 | $35 |
| Total Curr. Liab. | $35 | $43 | $97 | $66 |
| LT Debt | $9 | $11 | $29 | $30 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $9 | $11 | $29 | $31 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $12 | $13 | $15 | $18 |
| Total Liabilities | $45 | $54 | $126 | $96 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,730 | -$1,623 | -$1,488 | -$1,210 |
| AOCI | -$1 | -$1 | -$1 | -$0 |
| Other Equity | $1,799 | $1,741 | $1,711 | $1,610 |
| Total Equity | $69 | $117 | $222 | $400 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $113 | $171 | $349 | $496 |
| Net Debt | -$54 | $16 | -$14 | -$38 |